November 2015

U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.
Melanoma, the most aggressive type of skin cancer, is the leading cause of death from skin cancer. Patients with stage III melanoma are generally treated by surgery to remove the melanoma skin lesions and the nearby lymph nodes.

Researchers at University of California, San Diego have developed a model that could be used to predict a drug's side-effects on different patients.

Obese people need to have a diet rich in vitamin E as they require more than normal levels of the vitamin and at the same time they get less of it, suggests new research.

Indian Immunologicals Ltd (IIL), a leading biological company inaugurated its new bovine serum manufacturing facility in New Zealand.

Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday announced the launch of Nise D spray, which offers quick and targeted pain killing.

An Indian-origin researcher in the US has won a $150,000 grant to study genes linked to the deadly melanoma skin cancer, a media report said.

Taking vitamin D supplements can improve exercise performance and lower the risk of heart disease, said a new study.
Vitamin D, which is both a vitamin and a hormone, helps control levels of calcium and phosphate in the blood and is essential for the formation of bones and teeth.

Eating a diet rich in both soy protein and isoflavones can protect menopausal women from bone weakening and osteoporosis, according to a study.

[adsense:336x280:8701650588]

Researchers have developed cancer drug-packed 'grenades' armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours, according to two new studies.

There is new hope for cancer patients as Oxford University researchers have found the weak point of certain cancer cells which can be the target for new drugs -- mutations in a gene called SETD2.